Physician profile
Sunil S Reddy
NPI 1851787782
$1,568.55
in general payments reported to CMS, 2019-2025
15 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $246 · 2021: $206 · 2022: $557 · 2023: $224 · 2024: $217 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $559.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $450.16 | 2022-2025 | Panzyga |
| Intuitive Surgical, INC. | $443.46 | 2022 | |
| Adamas Pharmaceuticals, INC. | $143.15 | 2020-2021 | |
| Boston Scientific Corporation | $112.66 | 2020-2024 | |
| Dornier Medtech America, INC | $104.94 | 2023 | Dornier Medtech |
| Atricure, INC. | $73.18 | 2022 | |
| Akcea Therapeutics, INC. | $47.06 | 2020-2021 | |
| Horizon Therapeutics Plc | $39.79 | 2021 | |
| Vanda Pharmaceuticals INC. | $38.57 | 2020 | |
| Acorda Therapeutics, INC | $31.04 | 2021 | |
| Lundbeck LLC | $23.08 | 2023 | Vyepti |
| Upsher-Smith Laboratories LLC | $18.46 | 2020 | |
| Tersera Therapeutics LLC | $14.89 | 2021 | |
| Currax Pharmaceuticals LLC | $14.63 | 2021 | |
| Banner Life Sciences, LLC | $13.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.